WallStreetZenWallStreetZen

NASDAQ: ZVSA
Zyversa Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZVSA

Based on 1 analyst offering 12 month price targets for Zyversa Therapeutics Inc.
Min Forecast
$240.00+4,758.3%
Avg Forecast
$240.00+4,758.3%
Max Forecast
$240.00+4,758.3%

Should I buy or sell ZVSA stock?

Based on 1 analyst offering ratings for Zyversa Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ZVSA stock forecasts and price targets.

ZVSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-26

1 of 1

ZVSA revenue forecast

What is ZVSA's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$35.0M
Avg 2 year Forecast
$91.6M

ZVSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZVSA$4.94$240.00+4,758.30%Buy
VIRI$0.22N/AN/A
NEXI$3.06N/AN/A
ALZN$0.59N/AN/A
GOVX$1.82N/AN/A
View Top Biotech Stocks

Zyversa Therapeutics Stock Forecast FAQ

Is Zyversa Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ZVSA) stock is to Buy ZVSA stock.

Out of 1 analyst, 0 (0%) are recommending ZVSA as a Strong Buy, 1 (100%) are recommending ZVSA as a Buy, 0 (0%) are recommending ZVSA as a Hold, 0 (0%) are recommending ZVSA as a Sell, and 0 (0%) are recommending ZVSA as a Strong Sell.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.

What is ZVSA's revenue growth forecast for 2028-2029?

(NASDAQ: ZVSA) Zyversa Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Zyversa Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ZVSA's revenue for 2028 to be $29,221,360, with the lowest ZVSA revenue forecast at $29,221,360, and the highest ZVSA revenue forecast at $29,221,360.

In 2029, ZVSA is forecast to generate $76,472,299 in revenue, with the lowest revenue forecast at $2,663,318 and the highest revenue forecast at $150,281,280.

What is ZVSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ZVSA price target, the average ZVSA price target is $240.00, with the highest ZVSA stock price forecast at $240.00 and the lowest ZVSA stock price forecast at $240.00.

The Wall Street analyst predicted that Zyversa Therapeutics's share price could reach $240.00 by Mar 26, 2025. The average Zyversa Therapeutics stock price prediction forecasts a potential upside of 4,758.3% from the current ZVSA share price of $4.94.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.